3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Ovarian Neoplasms
2
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hemangiosarcoma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Disease Progression
1
Disease
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Lobular
1
Breast Cancer With Brain Metastasis
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
asciminib
8
Dasatinib
7
nilotinib
6
Imatinib Mesylate
5
Cyclophosphamide
4
ponatinib
3
fludarabine phosphate
3
bosutinib
3
Whole-Body Irradiation
3
ruxolitinib
2
letermovir
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Melphalan
2
Cyclosporine
2
Busulfan
2
venetoclax
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
decitabine and cedazuridine drug combination
1
Vorinostat
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
neratinib
×
1 year
×
Clear all
No trials found.